We are live on
!
Find out more
CCM
Cadence Capital Management Portfolio holdings
AUM
$415M
1-Year Est. Return
11.01%
This Fund
S&P 500
This Quarter
Est. Return
+5.02%
1 Year Est. Return
-11.01%
3 Year Est. Return
+0.72%
5 Year Est. Return
+39.08%
10 Year Est. Return
–
AUM
$2.09B
AUM Growth
-$289M
(-12%)
Cap. Flow
-$380M
Cap. Flow
% of AUM
-18.22%
Top 10 Holdings %
Top 10 Hldgs %
8.31%
Holding
697
New
113
Increased
76
Reduced
358
Closed
150
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
US Bancorp
USB
|
+$11.6M |
| 2 |
Phillips 66
PSX
|
+$11.1M |
| 3 |
MetLife
MET
|
+$10.1M |
| 4 |
Macy's
M
|
+$9.08M |
| 5 |
O'Reilly Automotive
ORLY
|
+$8.37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$17.7M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
+$10.7M |
| 3 |
GAP
The Gap Inc
GAP
|
+$8.4M |
| 4 |
United Airlines
UAL
|
+$8.14M |
| 5 |
SKX
Skechers
SKX
|
+$7.54M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 15.17% |
| 2 | Industrials | 14.75% |
| 3 | Technology | 13.58% |
| 4 | Healthcare | 12.19% |
| 5 | Financials | 10.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MJN
101
DELISTED
Mead Johnson Nutrition Company
MJN
| $6.25M | 0.3% |
+67,070
| New | +$5.86M |
|
102
Visa
V
$684B
| $6.24M | 0.3% |
118,388
-43,840
| -27% | -$2.29M |
|
103
NXP Semiconductors
NXPI
$58.3B
| $6.18M | 0.3% |
93,330
+60,960
| +188% | +$3.73M |
|
104
Truist Financial
TFC
$63.3B
| $6.13M | 0.29% |
155,374
-12,387
| -7% | -$475K |
|
|
CBM
105
DELISTED
Cambrex Corporation
CBM
| $6.12M | 0.29% |
295,406
-94,211
| -24% | -$1.91M |
|
106
HCA Healthcare
HCA
$87.1B
| $6.11M | 0.29% |
108,400
-15,700
| -13% | -$828K |
|
107
Alaska Air
ALK
$5.31B
| $6.07M | 0.29% |
127,800
-154,840
| -55% | -$7.37M |
|
108
Skyworks Solutions
SWKS
$9.39B
| $6.05M | 0.29% |
128,760
+25,090
| +24% | +$1.06M |
|
109
General Dynamics
GD
$104B
| $5.98M | 0.29% |
51,323
-20,097
| -28% | -$2.29M |
|
|
CTCT
110
DELISTED
CONSTANT CONTACT, INC COM
CTCT
| $5.96M | 0.29% |
+185,452
| New | +$5.17M |
|
111
JetBlue
JBLU
$2.28B
| $5.94M | 0.28% |
547,296
-139,244
| -20% | -$1.29M |
|
112
Oceaneering
OII
$4.87B
| $5.84M | 0.28% |
74,790
-11,060
| -13% | -$811K |
|
113
Tesla
TSLA
$1.23T
| $5.75M | 0.28% |
+359,400
| New | +$5.01M |
|
114
Dillards
DDS
$9.17B
| $5.74M | 0.28% |
+49,250
| New | +$5.14M |
|
115
Enanta Pharmaceuticals
ENTA
$368M
| $5.73M | 0.27% |
132,973
-29,127
| -18% | -$1.11M |
|
|
SIAL
116
DELISTED
SIGMA - ALDRICH CORP
SIAL
| $5.69M | 0.27% |
56,110
-5,300
| -9% | -$515K |
|
117
Honeywell
HON
$77.7B
| $5.64M | 0.27% |
67,538
-23,983
| -26% | -$2.01M |
|
118
Range Resources
RRC
$9.34B
| $5.64M | 0.27% |
64,840
-19,250
| -23% | -$1.72M |
|
119
CVS Health
CVS
$134B
| $5.6M | 0.27% |
74,334
-26,110
| -26% | -$1.97M |
|
120
Live Nation Entertainment
LYV
$40.5B
| $5.58M | 0.27% |
225,848
-48,064
| -18% | -$1.08M |
|
121
Eaton
ETN
$161B
| $5.55M | 0.27% |
71,917
-41,205
| -36% | -$3.06M |
|
|
CB
122
DELISTED
CHUBB CORPORATION
CB
| $5.27M | 0.25% |
57,203
-4,736
| -8% | -$436K |
|
123
Repligen
RGEN
$8.08B
| $5.27M | 0.25% |
231,051
-200,117
| -46% | -$3.56M |
|
|
EXAM
124
DELISTED
EXAMWORKS GROUP INC COM STK (DE)
EXAM
| $5.17M | 0.25% |
163,067
+3,960
| +2% | +$130K |
|
|
KOG
125
DELISTED
KODIAK OIL & GAS CORP
KOG
| $5.13M | 0.25% |
352,861
-137,812
| -28% | -$1.79M |
|
Similar funds
MGAI
FA
LWS
VCP
AIM
F
CPF
IA
Cadence Capital Management's Q2 2014 Portfolio in Review
As of Q2 2014, Cadence Capital Management held 697 positions worth $2.09B, down 12% from $2.37B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.
Cadence Capital Management withdrew a net $380M in Q2 2014, closing 150 positions and reducing 358 holdings. Its most notable exit was Alnylam Pharmaceuticals, an estimated $10.7M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 13% a quarter earlier, followed by Industrials and Technology.
Against the trend, Cadence Capital Management opened a new position in US Bancorp worth $12.1M.
- Cadence Capital Management's largest Q2 2014 buy was US Bancorp: 279,044 shares worth $12.1M.
- Cadence Capital Management added most to Wynn Resorts in Q2 2014, an estimated $7.23M increase.
- Cadence Capital Management's biggest Q2 2014 reduction was Apple, cutting an estimated $17.7M.
- Cadence Capital Management fully exited Alnylam Pharmaceuticals in Q2 2014, selling an estimated $10.7M.
- Cadence Capital Management's ten largest holdings make up 8.3% of its $2.09B portfolio in Q2 2014.
- Cadence Capital Management opened 113 new positions and closed 150 in Q2 2014.
- Cadence Capital Management's portfolio value fell 12% quarter-over-quarter to $2.09B.
Based on Cadence Capital Management's 13F filing for Q2 2014, filed 23 Jul 2014.